Heart Disease and the Human Genome Project

One person dies every 36 seconds from cardyovascular related issues in the us. Saker catherason, iam, c o of a biotac company called ver therapeutics has been studying heart disease and its genetic underpinnings. Through his research, using genetics, sake has been able to overturn long held beliefs about one of those variables, clusteral.